ABBV-CLS-7262

· AbbVie

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for ABBV-CLS-7262, covering 2024-07-01 to 2025-11-14. Get the full timeline:

Most recent: Clinical Trial Update: HEALEY ALS Platform Trial - Regimen F ABBV-CLS-7262 [Phase 2, Phase 3]